Despite Roche dropping $595M deal, Israeli startup Chiasma raises $33.8M for acromegaly drug
Israeli startup Chiasma in the midst of a hefty fundraise: It’s raised $33.8 million of a proposed $56.3 million round, according to regulatory filings. This comes as a timely vote of confidence – the company was expecting a $595 million deal that fell through over the summer. Chiasma’s lead product, oral octreotide, is being developed […]